Article
Molecular diagnosis of myopathies.
Rheumatic diseases clinics of North America - 1 May 2011
Gomez-Vargas Andrew, Baker Steven K
Abstract excerpt
Neuromuscular diseases (NMD) constitute a group of phenotypically and genetically heterogeneous disorders, characterized by (progressive) weakness and atrophy of proximal and/or distal muscles. The objective of molecular testing is to confirm the pathogenicity of a relevant sequence variation by correlating an individual's phenotype with what is expected in a given condition. Within the last two decades the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
